Imagine a world, when diagnosed with T1 or T2 Diabetes, where caretakers and the diagnosed were taught the basics on how to keep normoglycemic range. 2 week stay in hospital, 1 week SAD, 1 week LCHP. The feedback from the T1/T2 patient would be very interesting. #ATTD2023

Partha's first contribution to a discussion panel on connected pens when asked who would benefit from using them is 💯 ON POINT: 'it is not up to us to decide. We should not pre-judge who will and will not use what technology'. Yes yes yes! #dedoc #attd2023 Partha S Kar 🇮🇳🇬🇧🏏🎥

Welcome to #ATTD2023

#diabetes #diabestESP

« If you want something genuinely from your heart, others will follow you to change things » says Partha about fighting disparities - very inspirational talk #ATTD2023 #attdconf Partha S Kar 🇮🇳🇬🇧🏏🎥

A hard-hitting talk by Dr.V.Mohan sir on the advocacy, adoption of tech & disparities in India. Fabulous initiatives and technological solutions by MDRF across India - could extend pan India & across the developing nations. Advanced Technologies & Treatments for Diabetes #ATTD2023 Partha S Kar 🇮🇳🇬🇧🏏🎥 Tadej Battelino Jazz Sethi

Insulin sensitivity and glucose level change throughout the menstrual cycle, increasing the burden associated with TID management.

'Psyco-behavioral barriers to optimal glucose management in women with t1d across the age' @katharinebarnard
#ATTD2023

One of these moments Pratik Choudhary Emma Wilmot Lalantha Leelarathna Advanced Technologies & Treatments for Diabetes #ATTD2023 #berlin

Time In Tight Range (TITR) 70-140 mg/dL: a new metric in diabetes management. Are you with or against? Why? #ATTD2023

Lots of cool gadgets at #ATTD2023 . Robot reacts to glucose excursion is buddy for kids (and maybe adults too) with #diabetes .

I have type 1 diabetes. So what?

Bite me! 😂

Great presentation by Chantal Mathieu from the University of Leuven, Belgium, at Advanced Technologies & Treatments for Diabetes 2023.

#dedoc
#ATTD2023
#attd
#ATTD23
#diabetes

⭐️ من الأخبار الجميلة القادمة من
مؤتمر تقنيات السكري، برلين
#ATTD2023

اقتراب توفير حساس لا يقيس فقط
السكر، بل أيضا الكيتون😍👍

قياس الكيتون عبر الحساس يمثل
نقلة نوعية من ناحية أهمية اكتشاف
ارتفاع الكيتون مبكرا لمنع حدوث
حموضة الدم الكيتونية،
وكذلك تسهيل وتخفيف العبء
ع المرضى

.

That concludes #ATTD2023 . What a great experience this has been! #dedoc 💙

Collecting DIY Loopers* during ATTD 2023! N=22 (including myself 🙃) Many old friends and new!

*parents and developers included

#dedoc #ATTD2023 #WeAreNotWaiting #NothingAboutUsWithoutUs #opensource #offlabelbychoice

💠💠 Medtronic y su sistema AHCL con ingestas no anunciadas. Buenos resultados con hasta 80g de HdeC no anunciados #attd #ATTD23 #attd 2023

Menstrual cycle specific HCL algorithms for women with Type 1 #diabetes work in silico - now on to clinical trials... #ATTD2023

The obesity crises strikes adolescent t1ds. Dr Hamdy identifies the culprit. #ATTD2023

كلمات جميلة ترددت في أروقة وشاشات مؤتمر تقنيات السكري #ATTD2023

'استخدم بيانات حساس (مجس) السكر لإلقاء نظرة خاطفة على حياة الاشخاص المصابين بداء السكري ، وليس للحكم عليهم!' 👏🏻👏🏻👏🏻

Deberíamos ir más allá y buscar un TITR 70-140>50% para evitar por fin complicaciones? #ATTD2023

Continuous Ketone Monitoring #CKM will be available in a #FreeStyleLibre3 sensor. It’s been classified as an breakthrough discovery by #FDA U.S. FDA en Español News from #ATTD2023

Thank you to everyone that joined the #exercise and #T1D session today!! ⁦Advanced Technologies & Treatments for Diabetes⁩ #ATTD2023 ⁦Michael Riddell, PhD⁩ StanfordPedsEndo⁩